疏血通注射液对感染性休克患者组织灌注及预后的影响被引量：3

Effects of Shuxuetong injection on tissue perfusion and prognosis in septic shock patients

导出

摘要目的观察疏血通注射液对感染性休克患者组织灌注及预后的影响。方法将80例感染性休克患者随机分为2组,对照组40例予常规治疗,治疗组40例在对照组治疗基础上应用疏血通注射液治疗,2组均治疗7 d。观察2组治疗前后尿量、乳酸、尿素氮(BUN)、肌酐(Cr)、天冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、左室射血分数(LVEF)、心指数(CI),比较2组血管活性药物总用量及28 d病死率。结果 2组治疗后乳酸、BUN、Cr、AST、ALT均较本组治疗前降低(P<0.05),治疗组治疗后降低较对照组治疗后更明显(P<0.05);2组治疗后尿量、LVEF、CI均较本组治疗前增加(P<0.05),治疗组治疗后增加较对照组治疗后更明显(P<0.05)。治疗组多巴胺、多巴酚丁胺、去甲肾上腺素总用量少于对照组(P<0.05);治疗组28 d病死率低于对照组(P<0.05)。结论疏血通注射液可改善感染性休克患者的组织灌注,降低死亡率。 Objective To observe the effects of Shuxuetong injection on tissue perfusion and prognosis in septic shock patients. Methods 80 septic shock patients were randomly divided into two groups. 40 patients in control group were treated by routine therapy. 40 patients in treatment group were treated by Shuxuetong injection on the basis of Control group treatment. The treatment course was 7 days in two groups. The clinical indexes auch as urine volume, lactic acid, urea nitrogen, creatinine, aspartate aminotransferase （AST）, alanine aminotransferase （ ALT）, left ventricular ejection fraction （LVEF） and cardiac index were observed before and after treatment in two groups. The total volume of vasoactive drugs and 28 d case fatality rate were compared between two groups, Results The levels of lactic acid, urea nitrogen, creatinine, AST and ALT after treatment were decreased in two groups （P 〈 0.05 ）, and the decrease in treatment group was more obviously as compared with that in control group （ P 〈 0.05）. The urine volume, LVEF and cardiac index after treatment were increased in two groups （P 〈 0.05 ）, and the increase in treatment group was more obviously as compared with that in control group （P 〈 0.05）. The total dosage of dopamine, dobutamine and norepiephrine in treatment group was less than that in control group （ P 〈 0.05 ）. The 28 d case fatality rate in treatment group was lower than that in control group （P 〈 0.05）. Conclusion Shuxu- etong injection can improve tissue perfusion in septic shock patients, reduce the mortality.

作者董旭潘丽娜郭洁樊艳华贾琳武蕾张慧聪刘明王蕾魏树慧

机构地区河北省中医院重症医学科河北省无极县医院内五科河北省老年病医院功能科

出处《河北中医》 2015年第12期1858-1861,共4页 Hebei Journal of Traditional Chinese Medicine

基金 2012年度河北省科学技术研究与发展计划项目(编号:12277720)

关键词休克脓毒性灌流地龙三七水蛭注射剂 Shock Septic Perfusion Dilong Sanqi Shuizhi Injection

分类号 R631.405.3 [医药卫生—外科学] R972 [医药卫生—药品]

引文网络
相关文献

参考文献18

1王涛,夏永富,郝东,孙建荣,李志,韩沙沙,田焕焕,张晓荣,齐志江,孙婷,高福泉,王晓芝.乳酸在脓毒性休克早期诊断及目标导向治疗中的意义[J].中华危重病急救医学,2014,26(1):51-55. 被引量：64
2Zhou J, Pavlovic D, Willecke J, et al. Activated protein C improves pial microcirculation in experimental endo- toxemia in rats [ J ]. Microvasc Res, 2012,83 ( 3 ) : 276- 280.
3Grtindling M, Rickert S, Saeger D, et al. Acute high - dose sodium selenite administration improves intesti- nal microcirculation without affecting cytokine release in experimental endotoxemia [ J ]. J Trace Elem Med Biol,2009,23 (2) : 138 - 143.
4Segal N, Rees J, Convertino VA, et al. Improving mi- crocirculation with therapeutic intrathoraeic pressure regulation in a porcine model of hemorrhage [J ]. Re- suscitation,2011,82 Suppl 2 :S16 - 22.
5Lehmann C, Pavlovic D, Zhou J, et al. Intravenous free and dipeptide - bound glutamine maintains intestinal mieroeireulation in experimental endotoxemia [ J ]. Nu- trition, 2012,28 ( 5 ) : 588 - 593.
6严静.成人严重感染与感染性休克血流动力学监测与支持指南(2006)[J].中国实用外科杂志,2007,27(1):7-13. 被引量：135
7Groner W, WAnkelman JW, Harris AG, et al. Orthogo- nal polarization spectral imaging: a new mtaaod for study of the microcirculation [ J]. Nat Med, 1999,5 (10) :1209 - 1212.
8De Backer D, Creteur J, Preiser JC, et al. Microvascular blood flow is altered in patients with sepsis [ J ]. Am J Respir Crit Care Med,2002,166( 1 ) :98 -104.
9Spronk PE, Zandstra DF, Ince C. Bench - to - bed- side review: sepsis is a disease of the microcircula- tion [ J ]. Crit Care, 2004,8 (6) :462 - 468.
10Klijn E, Den Uil CA, Bakker J, et al. The heterogenei- ty of the microcirculation in critical illness [ J ]. Clin Chest Med, 2008,29 (4) : 643 - 654.

二级参考文献32

1汪建华,吴凤英,黄天才.疏血通治疗急性脑梗塞56例[J].陕西中医,2004,25(7):607-608. 被引量：16
2Wiersinga WJ. Current insights in sepsis:from pathogenesis to new treatment targets[J].{H}CURRENT OPINION IN CRITICAL CARE,2011,(05):480-486.
3Rivers E,Nguyen B,Havstad S. Early goal-directed therapy in the treatment of severe sepsis and septic shock[J].{H}New England Journal of Medicine,2001,(19):1368-1377.
4O'Neill R,Morales J,Jule M. Early Goal-directed Therapy (EGDT) for severe sepsis/septic shock:which components of treatment are more difficult to implement in a community-based emergency department[J].{H}JOURNAL OF EMERGENCY MEDICINE,2012,(05):503-510.
5Varpula M,Karlsson S,Ruokonen E. Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock[J].{H}Intensive Care Medicine,2006,(09):1336-1343.
6Rimachi R,Bruzzi de Carvahlo F,Orellano-Jimenez C. Lactate/pyruvate ratio as a marker of tissue hypoxia in circulatory and septic shock[J].{H}Anaesthesia and Intensive Care,2012,(03):427-432.
7Sakamoto Y,Mashiko K,Matsumoto H. Selection of acute blood purification therapy according to severity scorc and blood lactic acid value in patients with septic shock[J].lndian J Crit Care Med,2010,(04):175-179.
8Dellinger RP,Levy MM,Carlet JM. Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2008[J].{H}Intensive Care Medicine,2008,(01):17-60.
9Levy MM,Fink MP,Marshall JC. 2001 SCCM / ESICM /ACCP/ATS/SIS International Sepsis Definitions Conference[J].{H}Intensive Care Medicine,2003,(04):530-538.
10肖海鹏;杨惠玲.临床病理生理学[M]{H}北京:人民卫生出版社,200954-55.